Metabolic investigations according to patterns of presentation
Presentation | Condition | Specific investigations | ||
Encephalopathy | Urea cycle defects | Urine amino acids | ||
Organic acidaemias and MSUD | Urine organic acids | |||
Plasma amino acids | ||||
Blood carnitine and acylcarnitine profile | ||||
Skin biopsy for enzyme analysis | ||||
Fatty acid oxidation defects | As above, plus: | |||
Blood DNA mutation analysis | ||||
Primary lactic acidoses (e.g. pyruvate dehydrogenase | CSF lactate | |||
deficiency, pyruvate carboxylase deficiency and | Mitochondrial DNA—blood and muscle | |||
respiratory chain defects) | Muscle biopsy—histology and electron microscopy | |||
Skin biopsy—enzymes of pyruvate metabolism | ||||
Non-ketotic hyperglycinaemia | Plasma and CSF amino acids | |||
Enzyme analysis on transformed lymphoblasts | ||||
Molybdenum cofactor deficiency | Urine sulphite (dipstick) | |||
Urine amino acids | ||||
Plasma uric acid | ||||
Skin biopsy for enzyme analysis | ||||
Pyridoxine dependent seizures | Trial of pyridoxine under EEG observation | |||
Hypoglycaemia | Fatty acid oxidation defects | As under encephalopathy | ||
Hypopituitarism | Hormone levels (growth hormone, cortisol, ACTH, insulin, and C peptide) | |||
Adrenal dysfunction | ||||
Hyperinsulinism | ||||
Gluconeogenic defects (e.g. fructose-1,6 bisphosphatase deficiency) | Blood gases (metabolic acidosis) | |||
Plasma lactate | ||||
Urine organic acids (for glycerol) | ||||
Enzyme assay—leucocytes or liver biopsy | ||||
Glycogen storage disease (types I, III, VI, IX) | Plasma lactate | |||
Enzyme assay—leucocytes or liver biopsy | ||||
Histology on liver biopsy | ||||
Secondary to organic acidaemias or disorders affecting the liver | As stated under respective sections | |||
Liver disease | Galactosaemia | Beutler test | ||
Red cell galactose-1-phosphate | ||||
DNA mutation analysis | ||||
Ophthalmology assessment for cataracts | ||||
Tyrosinaemia type I | Plasma amino acids | |||
Urine organic acids | ||||
Investigations for renal Fanconi's syndrome | ||||
α1 Antitrypsin deficiency | Serum α1 antitrypsin | |||
Protease typing | ||||
Neonatal haemochromatosis | Serum ferritin | |||
Liver biopsy | ||||
Niemann–Pick C | Foam cells on bone marrow aspitrate, blood film, liver biopsy | |||
Filipin staining on skin biopsy | ||||
Mitochondrial (respiratory chain) defects | CSF lactate | |||
Mitochondrial DNA—blood and muscle | ||||
Muscle and liver biopsy—histology and electron microscopy | ||||
Cardiomyopathy | Pompe's disease (GSD type II) | Enzyme assay on lymphocytes or skin fibroblasts | ||
Fatty acid oxidation defects | As stated under encephalopathy | |||
Mitochondrial (respiratory chain) defects | As stated under liver disease | |||
CDG 1a syndrome | Serum transferrin isoelectric focusing | |||
Enzyme assay on skin biopsy | ||||
Lysosomal storage disorders | White cell enzymes | |||
Urine oligosaccharides and mucolpolysaccharides | ||||
Skin biopsy | ||||
Dysmorphism | Lysosomal storage disorders | As under cardiomyopathy | ||
Disorders of sterol synthesis | Urine organic acids | |||
Plasma 7-dehydrocholesterol | ||||
Skin biopsy | ||||
CDG syndrome | Serum transferrin isoelectric focusing | |||
Enzyme assay on skin biopsy | ||||
Glutaric aciduria type II | Urine organic acids | |||
Blood carnitine/acylcarnitine profile | ||||
Skin biopsy |